Sale!

SHINGRIX

RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN-0.5ML

2-8* C
MRP : MRP 10,999.00
Price : 8,500.00
You Save : 2,499.00 (22.72%)

1 vial(s) of 0.5ml

Buy Now

Shingrix 0.5ml vaccine contains a non-live, recombinant Varicella-zoster virus (VZV) antigen, not a live attenuated virus as previously believed. It belongs to a class of vaccines designed to prevent shingles (herpes zoster) and its major complication, post-herpetic neuralgia — a persistent nerve pain that can follow a shingles outbreak.

Shingrix is recommended for adults aged 50 and older to help protect against herpes zoster. Shingles results from the reactivation of the VZV, which remains dormant in nerve tissue after a person recovers from chickenpox. When reactivated, it causes a painful rash and, in some cases, long-term nerve pain. Unlike earlier live vaccines, Shingrix uses a non-live component and is considered safer and more effective, especially in older adults and those with weakened immune systems.

This vaccine is not intended to prevent chickenpox (the primary varicella infection). Before receiving the vaccine, it is essential to inform your healthcare provider if you have any known allergies to components of the vaccine, or if you have conditions such as cancer, blood disorders, or an immunocompromised state like HIV.

Shingrix is not approved for use in individuals under 18, and its safety in children has not been established. If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor to determine whether vaccination is appropriate